Panelists
*Gregory Campbell, U.S. Food and Drug Administration  *Thomas Fleming, University of Washington  *Mohammad Huque, FDA  *Jon Norton, FDA  *Steven Snapinn, Amgen/GBE  *Greg Soon, FDA  *Bob Temple, FDA 

Keywords: